<DOC>
	<DOCNO>NCT01992978</DOCNO>
	<brief_summary>Surgical resection effective treatment primary secondary liver tumor . Technical innovation mainly focus minimize bleed transection hepatic parenchyma excessive hemorrhage need blood transfusion associate increase postoperative morbidity mortality . Recently , radiofrequency-assisted（RFA）hepatectomy develop rapidly gain widespread acceptance treatment hepatocellular carcinomas（HCC），but influence prognosis HCC patients，especially cirrhosis，is still controversial . Therefore , design prospective clinical trial explore effect RFA hepatectomy versus conventional hepatectomy outcomes perioperative period prognosis HCC patient cirrhosis .</brief_summary>
	<brief_title>Radiofrequency-assisted Hepatectomy Outcomes HCC Patients With Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Aged 18 65 year , gender restriction . Clinical diagnosis resectable HCC . Preoperative liver function test show ChildPugh Class A B. Indocyanine green retention 15 minute ( ICG15 ) &lt; 30 % . Acceptable clot profile : platelet count ＞ 50 x 109/L prolonged prothrombin time &lt; 5 second . Enough relative residual liver volume ( % RLV ) ≥ 40 % . No tumor invasion primary branch portal vein , hepatic vein , inferior vena cava . No antitumor therapy receive treatment . No metastasis lymphnode organ . Written consent inform assign . Pregnancy . Intraoperative finding tumor rupture，extrahepatic tumor lymphnode metastasis . Tumor invasion primary branch portal vein , hepatic vein , inferior vena cava .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>radiofrequency-assisted（RF）</keyword>
	<keyword>hepatectomy</keyword>
	<keyword>postoperative liver injury</keyword>
</DOC>